225 related articles for article (PubMed ID: 29352051)
1. Long-Term Cognitive Functioning in Testicular Germ-Cell Tumor Survivors.
Chovanec M; Vasilkova L; Setteyova L; Obertova J; Palacka P; Rejlekova K; Sycova-Mila Z; Kalavska K; Svetlovska D; Cingelova S; Mladosievicova B; Mardiak J; Mego M
Oncologist; 2018 May; 23(5):617-623. PubMed ID: 29352051
[TBL] [Abstract][Full Text] [Related]
2. Long-term sexual functioning in germ-cell tumor survivors.
Chovanec M; Vasilkova L; Petrikova L; Obertova J; Palacka P; Rejlekova K; Sycova-Mila Z; Kalavska K; Svetlovska D; Mladosievicova B; Mardiak J; Mego M
BMC Cancer; 2020 Aug; 20(1):779. PubMed ID: 32819309
[TBL] [Abstract][Full Text] [Related]
3. Sexual Function in a Nationwide Cohort of 2,260 Survivors of Testicular Cancer after 17 Years of Followup.
Bandak M; Lauritsen J; Johansen C; Kreiberg M; Skøtt JW; Agerbaek M; Holm NV; Daugaard G
J Urol; 2018 Oct; 200(4):794-800. PubMed ID: 29730199
[TBL] [Abstract][Full Text] [Related]
4. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
[TBL] [Abstract][Full Text] [Related]
5. Cognitive impairment and biomarkers of gut microbial translocation in testicular germ cell tumor survivors.
Chovanec M; Kalavska K; Obertova J; Palacka P; Rejlekova K; Sycova-Mila Z; Orszaghova Z; Lesko P; De Angelis V; Vasilkova L; Svetlovska D; Mladosievicova B; Mardiak J; Pastorek M; Vlkova B; Celec P; Mego M
Front Oncol; 2023; 13():1146032. PubMed ID: 37025582
[TBL] [Abstract][Full Text] [Related]
6. Quality-of-Life Analysis of the German Prospective Multicentre Trial of Single-cycle Adjuvant BEP Versus Retroperitoneal Lymph Node Dissection in Clinical Stage I Nonseminomatous Germ Cell Tumours.
Flechtner HH; Fischer F; Albers P; Hartmann M; Siener R;
Eur Urol; 2016 Mar; 69(3):518-25. PubMed ID: 26620368
[TBL] [Abstract][Full Text] [Related]
7. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological features and survival of testicular tumours in a Southeast Asian university hospital: a ten-year review.
Tan GH; Azrif M; Shamsul AS; Ho CC; Praveen S; Goh EH; Bahadzor B; Ismail F; Zulkifli MZ
Asian Pac J Cancer Prev; 2011; 12(10):2727-30. PubMed ID: 22320982
[TBL] [Abstract][Full Text] [Related]
9. Long-term toxicity of the treatment for germ cell-cancer. A review.
Maroto P; Anguera G; Martin C
Crit Rev Oncol Hematol; 2018 Jan; 121():62-67. PubMed ID: 29279100
[TBL] [Abstract][Full Text] [Related]
10. [Results of the German studies (MAHO) for treatment of testicular germ cell tumors in children--an update].
Schmidt P; Haas RJ; Göbel U; Calaminus G
Klin Padiatr; 2002; 214(4):167-72. PubMed ID: 12165897
[TBL] [Abstract][Full Text] [Related]
11. Quality of life in long-term survivors of nonseminomatous germ cell testicular tumors.
Douchez J; Droz JP; Desclaux B; Allain Y; Fargeot P; Caty A; Charrot P
J Urol; 1993 Mar; 149(3):498-501. PubMed ID: 8382321
[TBL] [Abstract][Full Text] [Related]
12. Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS).
Rothermundt C; Thurneysen C; Cathomas R; Müller B; Mingrone W; Hirschi-Blickenstorfer A; Wehrhahn T; Ruf C; Rothschild S; Seifert B; Terbuch A; Grassmugg T; Woelky R; Fankhauser C; Kunit T; Fischer N; Inauen R; Kamradt J; Ziegler K; Haynes A; Jüni P; Gillessen S
Swiss Med Wkly; 2018; 148():w14640. PubMed ID: 30044478
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemotherapy after orchiectomy in high-risk patients with clinical stage I non-seminomatous testicular cancer.
Studer UE; Fey MF; Calderoni A; Kraft R; Mazzucchelli L; Sonntag RW
Eur Urol; 1993; 23(4):444-9. PubMed ID: 7687549
[TBL] [Abstract][Full Text] [Related]
14. Age-related variation and predictors of long-term quality of life in germ cell tumor survivors.
Hartung TJ; Mehnert A; Friedrich M; Hartmann M; Vehling S; Bokemeyer C; Oechsle K
Urol Oncol; 2016 Feb; 34(2):60.e1-6. PubMed ID: 26480898
[TBL] [Abstract][Full Text] [Related]
15. Orchiectomy and radiotherapy for stage I-II testicular seminoma: a prospective evaluation of short-term effects on body image and sexual function.
Wortel RC; Ghidey Alemayehu W; Incrocci L
J Sex Med; 2015 Jan; 12(1):210-8. PubMed ID: 25370897
[TBL] [Abstract][Full Text] [Related]
16. Management of clinical stage I testicular seminoma: active surveillance versus adjuvant chemotherapy.
Ondrusova M; Ondrus D; Miskovska V; Kajo K; Szoldova K; Usakova V; Stastna V
Int Urol Nephrol; 2015 Jul; 47(7):1143-7. PubMed ID: 25982582
[TBL] [Abstract][Full Text] [Related]
17. Testicular germ cell tumors with sarcomatous components: an analysis of 33 cases.
Guo CC; Punar M; Contreras AL; Tu SM; Pisters L; Tamboli P; Czerniak B
Am J Surg Pathol; 2009 Aug; 33(8):1173-8. PubMed ID: 19561445
[TBL] [Abstract][Full Text] [Related]
18. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
[TBL] [Abstract][Full Text] [Related]
19. Testicular germ cell tumors in boys <10 years: results of the protocol MAHO 98 in respect to surgery and watch & wait strategy.
Göbel U; Haas R; Calaminus G; Botorek P; Schmidt P; Teske C; Schönberger S; Schneider DT; Harms D
Klin Padiatr; 2013 Nov; 225(6):296-302. PubMed ID: 24158884
[TBL] [Abstract][Full Text] [Related]
20. Sexuality and body image in long-term survivors of testicular cancer.
Rossen P; Pedersen AF; Zachariae R; von der Maase H
Eur J Cancer; 2012 Mar; 48(4):571-8. PubMed ID: 22197218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
